23 May. 2018

Jean S Campbell

Hosted by Javier Vaquero

  • Wednesday, 23rd
  • 16h / IiSGM
  • MAD



The LiverSeminars Program is an educational activity in which experts in the Hepatology field will come to one of the two organizing institutions (IDIBAPS in Barcelona, IiSGM in Madrid) to spend a whole day sharing basic and translational science.

Visits will always have the same agenda: during the morning, the Expert will be able to meet in private with scientists from research centres geographically close to the Institution that welcomes him (please book your time slot at the “meet the speaker” tab), in the afternoon we will have the seminar itself that will be live broadcasted to the Institute that does not host the speaker.

Please note that activities are not restricted to the personnel from the organizing institutions. In this page you will find detailed information about the invited Speakers and scientific topics that will be covered during this academic year.

  • 9:00-10:00 SLOT TIME ALREADY BOOKED Jean S Campbell
  • 10:00-11:00 SLOT TIME ALREADY BOOKED Jean S Campbell
  • 11:00-12:00 SLOT TIME ALREADY BOOKED Jean S Campbell
  • 12:00-13:00 SLOT TIME ALREADY BOOKED Jean S Campbell

Dr. Jean Campbell

Dr. Jean Campbell trained with Drs. Edwin Krebs and Bennett Shapiro after receiving her PhD from the University of Wisconsin-Madison. She has had a long-standing interest in understanding basic mechanisms of physiologic systems, such as the regulation of liver regeneration or mechanisms of tumor resistance. Her research projects follow the ‘red thread’ of identifying growth factor and cytokine signal transduction pathways, and characterizing selective inhibitors to block these pathways in disease or cancer. These interests were the motive for Dr. Campbell’s productive collaboration with Dr. Nelson Fausto that lasted over a decade. In 2014, Dr. Campbell received the Nelson Fausto Distinguished Faculty Mentor Award.

Dr. Campbell broadened her research experience into the realm of clinical trials in the private sector as the VP of Discovery Research at Oncosec Medical, a biotechnology company developing immune-stimulating intratumoral approaches to treat cancer.

Currently, Dr. Campbell is investigating mechanisms of tumor resistance in immune-oncology, particularly with chimeric antigen receptor T-cell therapies at the Fred Hutchinson Cancer Research Center, and University of Washington, Departments of Pathology and Surgery. Using a variety of tissue-based approaches, Dr. Campbell also collaborates with academic research groups and biotechnology companies on clinical biomarker studies.


Find below the video recording as soon as it is available.


The LiverSeminars Program is distributed along the 2019/2020 academic year. Find herein the upcoming seminars.


The LiverSeminars Program is possible thanks to the support from these private and public entities.